Order for iclusig 30MG tab
Ended Awarded
- Contract number
- 36C26125N0761
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $14,434
Award facts
- Contract value 100% obligated
- $14,434.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
About this award
Takeda Pharmaceuticals America, Inc. has been awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 for the supply of ICLUSIG 30mg tablets, with a ceiling value of $14.4K. The contract was awarded on September 25, 2025, with an ultimate completion date of December 25, 2025, under firm fixed-price terms with no small business set-aside designation. This delivery order is placed against Takeda's General Services Administration Schedule for Pharmaceuticals and Drugs, which allows the VA to efficiently procure pharmaceutical products for delivery to the Place of Performance in Cambridge, Massachusetts.
This award represents a continuation of Takeda's established role as a critical supplier of ICLUSIG, a specialized oncology medication, to the VA system. The company maintains significant federal contract vehicles including a $2.9B Federal Supply Schedule contract through September 2030 and a $123.5M single-award Blanket Purchase Agreement focused specifically on ICLUSIG supply to VA medical facilities through the National Acquisition Center. These established procurement mechanisms enable VA facilities and Veterans Integrated Service Networks to place individual delivery orders efficiently for critical cancer treatments, supporting the VA's mission to provide specialized pharmaceutical care to veterans.
Quick answers
Who was awarded contract 36C26125N0761?
36C26125N0761 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on September 25, 2025.
How much is contract 36C26125N0761 worth?
The government has obligated $14,434 on 36C26125N0761.
Is contract 36C26125N0761 an order under another contract?
Yes. 36C26125N0761 is a delivery order under 36F79725D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0761 competed?
The extent of competition for 36C26125N0761 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award